Nexpoint Credit Strategies Fund (NHF) 21.65

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nexpoint Credit Strategies Fund (NHF) 21.65 $NHF

NexPoint Credit Strategies Fund Announces the Regular Monthly Dividend
PR Newswire - Fri Jul 01, 6:09PM CDT
NexPoint Credit Strategies Fund (NYSE: NHF) ("NHF" or the "Fund" today announced its regular monthly dividend on its common stock of $.24 per share. The dividend will be payable on July 29, 2016 to shareholders of record at the close of business July 22, 2016.
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund Announces Regular Monthly Dividend and Amendment to its Dividend Reinvestment Plan
PR Newswire - Wed Mar 02, 6:17PM CST
NexPoint Credit Strategies Fund ("NHF" or the "Fund" (NYSE: NHF) today announced its regular monthly dividend on its common stock of $.24 per share. The dividend will be payable on March 31, 2016 to shareholders of record at the close of business March 24, 2016.
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund declares dividend of USD0.24 per share for February 2016
M2 - Fri Feb 05, 3:02AM CST
NexPoint Credit Strategies Fund (NYSE:NHF) on Thursday released its regular common stock dividend of USD0.24 per share for February 2016.
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund declares monthly dividend
M2 - Thu Jan 07, 5:10AM CST
NexPoint Credit Strategies Fund (NYSE: NHF) said it has declared a regular monthly dividend on its common stock of USD0.24 per share. The dividend will be payable on January 29, 2016 to shareholders of record at the close of business January 22, 2016. The fund is a closed-end fund managed by NexPoint Advisors, L.P., an affiliated adviser of Highland Capital Management, L.P. The fund invests primarily in below investment grade debt and equity and has the ability to hedge risk. The Manager attempts to deliver consistent returns in excess of the Credit Suisse Hedge Fund and the HFRX Global Hedge Fund indices in a transparent, registered fund format with consistent monthly dividends.
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund declares monthly dividend of USD0.24 per share
M2 - Tue Jan 05, 3:06AM CST
NexPoint Credit Strategies Fund (NYSE:NHF) announced on Monday that it will pay a regular monthly common stock dividend of USD0.24 per share.
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund declares dividend of USD0.24 per share for November 2015
M2 - Tue Nov 03, 3:00AM CST
NexPoint Credit Strategies Fund (NYSE:NHF) announced on Monday that it will pay a regular monthly common stock dividend of USD0.24 per share for November 2015.
NHF: 21.65 (+0.05)

NexPoint Details Superior Investment Track Record within TICC Capital Corp.'s Investment Strategy
BusinessWire - Wed Oct 21, 4:53PM CDT
NexPoint Advisors, L.P. (together with its affiliates, "NexPoint" today released data detailing NexPoint's superior past investment performance that clearly demonstrates its outperformance within the asset classes primarily underlying the investment portfolio of TICC Capital Corp. (NASDAQ: TICC) ("TICC" or the "Company". This track record further substantiates why NexPoint is best positioned to serve TICC's stockholders, and why TICC stockholders should protect their interests and investment by voting on the BLUE proxy card ahead of the October 27 special meeting of stockholders (the "Special Meeting".
NHF: 21.65 (+0.05), TICC: 5.53 (+0.03)

NexPoint Credit Strategies Fund Effects Reverse Stock Split
PR Newswire - Wed Oct 07, 6:12PM CDT
NexPoint Credit Strategies Fund (the "Fund" (NYSE: NHF) effected its 1-for-4 reverse stock split of the Fund's issued and outstanding shares on October 6, 2015. As a result of the reverse stock split, every 4 outstanding Fund shares (CUSIP # 65340G106) were converted into 1 share (CUSIP # 65340G 205), thereby reducing by a factor of 4 the number of shares outstanding. Stockholders hold the same percentage of the Fund's outstanding common stock immediately following the reverse stock split as such stockholder held immediately prior to the reverse stock split, subject to adjustments for fractional shares resulting from the reverse stock split. Stockholders will be paid cash for any fractional shares resulting from the reverse stock split once the reverse stock split is processed by the Fund's transfer agent, American Stock Transfer & Trust Company, LLC ("AST".
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund declares October 2015 dividend of USD0.06 per share
M2 - Fri Oct 02, 3:52AM CDT
NexPoint Credit Strategies Fund (NYSE:NHF) reported on Thursday that it will pay a regular monthly dividend of USD0.06 per share on its common stock.
NHF: 21.65 (+0.05)

NexPoint Advisors, L.P. Announces Favorable Judgment for NexPoint Credit Strategies Fund
PR Newswire - Mon Sep 28, 3:48PM CDT
NexPoint Advisors, L.P. announces that the NexPoint Credit Strategies Fund (NYSE: NHF) ("NHF" or the "Fund" stands to benefit from a $287.5 million litigation judgment, of which the Fund would receive $51 million, subject to counsel fees, expenses and other additional calculations. The Fund also will be seeking $13.7 million in additional pre-judgment interest. The judgment remains subject to appeal, and no assurance can be given that the Fund will be successful in seeking pre-judgment interest; it is not known when or how much, if any, of these monies the Fund will receive. As a result in accordance with GAAP, this judgment is not currently recorded as an asset of the fund.
NHF: 21.65 (+0.05)

NexPoint Credit Strategies Fund declares dividend of USD0.06 per share for August 2015
M2 - Tue Aug 04, 6:36AM CDT
NexPoint Credit Strategies Fund (NYSE:NHF) announced on Tuesday that it will pay a regular monthly common stock dividend of USD0.06 per share.
NHF: 21.65 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading